CPS by CPhA vs MS 2024 Criteria

CPS (formerly RxTx) has a new appearance. CPS is still the reliable, evidence-based drug resource it has always been and provides essential drug information at the point-of-care for health care practitioners. Now offering two subscription options – CPS Drug Information or CPS Full Access. CPS Drug Information is the Canadian standard for drug monographs, containing thousands of products including monographs for drugs, vaccines, natural health products and medical devices, approved by Health Canada. CPS Full Access includes all content from CPS Drug Information and the most current, evidence-based therapeutic information and non-prescription therapy for most common conditions, with cross-referenced drug tables and algorithms and DC condition-based drug tables. Both subscriptions types provide critical updates such as warnings and advisories; and useful tools such as medical calculators.

This app helps clinicians apply the McDonald Criteria 2024 for Multiple Sclerosis diagnosis through a structured, step-by-step approach. Designed for neurologists, residents, medical students and healthcare professionals, it transforms complex criteria into clear clinical decisions.